aztreonam and avibactam

aztreonam has been researched along with avibactam in 68 studies

Research

Studies (68)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	25 (36.76)	24.3611
2020's	43 (63.24)	2.80

Authors

Authors	Studies
Bethel, CR; Bonomo, RA; Cmolik, A; Domitrovic, TN; Goldberg, JA; Hoyer, D; Hujer, AM; Hujer, KM; Jacobs, MR; Kreiswirth, BM; Kumar, V; Logan, LK; Marshall, EK; Marshall, SH; Nguyen, H; O'Shea, M; Papp-Wallace, KM; Perez, F; Plummer, MS; Rudin, SD; Spencer, EJ; van den Akker, F; van Duin, D	1
Doumith, M; Livermore, DM; Maharjan, S; Mushtaq, S; Warner, M; Woodford, N; Zhang, J	1
Abuzenadah, AM; Alam, Q; Azhar, EI; Damanhouri, GA; Jabir, NR; Kamal, MA; Shakil, S; Tabrez, S	1
Crandon, JL; Nicolau, DP	1
Chen, H; He, W; Li, H; Nichols, WW; Testa, R; Wang, H; Wang, Q; Wang, X; Wang, Z; Zhang, F; Zhao, C	1
Alm, RA; Johnstone, MR; Lahiri, SD; McLaughlin, RE; Olivier, NB; Ross, PL	1
Alm, RA; Johnstone, MR; Lahiri, SD	1
Abdelhamed, AM; Bajaksouzian, S; Bonomo, RA; Foster, AN; Gatta, JA; Jacobs, MR; Nichols, WW; Papp-Wallace, KM; Testa, R; Winkler, ML	1
Biedenbach, DJ; Bouchillon, SK; Bradford, PA; Kazmierczak, K; Sahm, DF	1
Bradford, PA; Eakin, AE; Harris, JJ; Kim, A; McLaughlin, RE; O'Donnell, JP; Patey, S; Singh, R; Tanudra, MA	1
Cole, NC; Cunningham, SA; De, PP; Harris, KA; Koh, TH; Kohner, PC; Krause, KM; Menon, SR; Patel, R; Vasoo, S	1
Cattoir, V; Derdouri, S; Dupont, H; Emond, JP; Gaillard, N; Gaillot, O; Girard de Courtilles, M; Goetgheluck, AS; Lecuru, M; Lemaire, B; Mammeri, H; Plassart, C	1
Beaudoin, ME; Derendorf, H; Frank, C; Heuberger, JA; Kissel, M; Löblein, KI; Lux, C; Mulder, MB; Schuck, VJ; Strasser, S; Sy, SK; Tremmel, R; Zhuang, L	1
Biedenbach, DJ; Bouchillon, SK; Bradford, PA; de Jonge, BL; Hackel, M; Kazmierczak, KM; Rabine, S; Sahm, DF	1
Cannatelli, A; Di Pilato, V; Giani, T; Nichols, WW; Rossolini, GM; Testa, R	1
Baumert, P; Feihl, S; Gastmeier, P; Gebhardt, F; Gölz, H; Hamprecht, A; Kern, WV; Knobloch, J; Kola, A; Mischnik, A; Obermann, B; Peter, S; Querbach, C; Rohde, A; Seifert, H; Tacconelli, E; Willmann, M	1
Arthur, M; Ourghanlian, C; Soroka, D	1
Beaudoin, ME; Derendorf, H; Schuck, VJ; Sy, S; Xia, H; Zhuang, L	1
Avison, MB; Brem, J; Cain, R; Calvopiña, K; Fishwick, CWG; Heesom, KJ; Hinchliffe, P; Johnson, S; Lohans, CT; Schofield, CJ; Spencer, J	1
Brem, J; Lohans, CT; Schofield, CJ	1
Cheng, B; Chew, KL; Lin, RTP; Octavia, S; Tay, MKL; Teo, JWP	1
Amicosante, G; Conte, V; Giani, T; Perilli, M; Piccirilli, A; Rossolini, GM; Tascini, C	1
Adier, C; Chauzy, A; Couet, W; Lamarche, I; Marchand, S	1
Buyck, J; Chauzy, A; Couet, W; de Jonge, BLM; Grégoire, N; Marchand, S	1
Hsu, AJ; Tamma, PD	1
Adier, C; Buyck, J; Chauzy, A; Couet, W; de Jonge, B; Gaelzer Silva Torres, B; Grégoire, N; Marchand, S	1
Bonomo, RA; Chavda, KD; Chen, L; Du, H; Kreiswirth, BN; Lv, J; Niu, S; Pitout, JDD; Tang, YW; Wei, J; Zhang, H; Zou, C	1
Budding, AE; Schouls, L; Sieswerda, E; Sträter, J; van den Berg, RB; van den Brand, M; van Dijk, K	1
Arenz, D; Calbo, E; Cisneros, JM; Cornely, OA; Horcajada, JP; Jiménez-Jorge, S; Luckey, A; O'Brien, S; Queckenberg, C; Raber, S; Rodríguez-Hernández, MJ; Rosso-Fernández, CM; Tallón-Aguilar, L; Torre-Cisneros, J; Turner, G; Zettelmeyer, U	1
Bhagwat, S; Joshi, P; Palwe, S; Patel, M; Periasamy, H; Shrivastava, R	1
Anderson, K; Bhatnagar, A; Boyd, S; Brown, AC; Elkins, CA; Karlsson, M; Lonsway, D; Lutgring, JD; Machado, MJ; Patel, JB; Ransom, E; Rasheed, JK; Reese, N	1
Huang, A; Niu, S; Wang, D; Wei, J; Zou, C	1
Boissonneault, KR; Bonomo, RA; Bulitta, JB; Chambers, HF; Eakin, AE; Fowler, VG; Holden, PN; Lodise, TP; O'Donnell, N; Smith, NM; Tao, X; Tsuji, BT; Zhou, J	1
Ashraf, T; Barathan, G; Darwish, D; Ghazawi, A; Hashmey, R; Pál, T; Rizvi, TA; Sonnevend, Á	1
Esposito, S; Papaparaskevas, J; Stone, GG	1
Abbott, IJ; Basu, G; Bergin, P; Cairns, KA; Corallo, CE; Griffin, DWJ; Hall, V; Khan, SF; Love, J; Martin, GE; Meher-Homji, Z; Morrissey, CO; Peleg, AY; Sharma, A; Sia, C; Spencer, A; Stewart, JD	1
Arends, SJR; Carvalhaes, CG; Castanheira, M; Mendes, RE; Sader, HS	1
Cowart, MC; Ferguson, CL	1
Anderson, K; Bhatnagar, A; Boyd, S; Brown, AC; Elkins, CA; Karlsson, M; Lonsway, D; Lutgring, JD; Machado, MJ; Patel, JB; Ransom, EM; Rasheed, JK; Reese, N	1
Baldelli, S; Cattaneo, D; Di Paolo, A; Falcone, M; Galfo, V; Leonildi, A; Menichetti, F; Pai, MP; Tagliaferri, E; Tiseo, G	1
Arhin, FF; Estabrook, M; Kazmierczak, KM; Sahm, DF; Stone, GG; Wise, M	1
Baclet, N; Cabaret, P; Carpentier, B; Diarra, A; Dubreuil, L; Georgel, AF; Pascal, L; Weyrich, P	1
Nordmann, P; Poirel, L; Sadek, M	1
Dong, D; Feng, K; Gong, H; Jia, N; Liu, Y; Lv, Z; Martins, FS; Sy, S; Sy, SKB; Yu, M; Zhang, J; Zhu, P; Zhu, S; Zhu, Y	1
Chakraborty, T; Falgenhauer, L; Imirzalioglu, C; Nordmann, P; Sadek, M; Yao, Y	1
Arhin, FF; Castanheira, M; Doyle, TB; Mendes, RE; Sader, HS; Streit, JM	1
Ellaby, N; Livermore, DM; Mushtaq, S; Vickers, A; Woodford, N	1
Martínez-Marcos, FJ; Montero-Pérez, O; Pelaez Bejarano, A; Sánchez-Del Moral, R	1
Aimar, G; Albano, G; Andrews, MC; Anwar, TM; Bai, X; Bati, S; Beerli, C; Bergwerk, A; Bigaud, M; Bitew, A; Borel, C; Boyko, M; Brahimi, Y; Briard, E; Bristow, C; Bronner, G; Burgy, M; Burton, E; Cai, X; Cao, J; Carinato, H; Carro, C; Cerri, GB; Chadha, R; Chai, W; Chen, L; Chen, M; Chen, X; Chen, XF; Chen, Y; Chen, ZJ; Cheng, W; Class, CA; Coliat, P; Cooper, ZA; Cortellini, A; Cui, Y; D'Orazio, C; Dafale, NA; Dai, Y; Davies, MA; Davis, R; Dawson, LF; De Macedo, MP; Demarchi, M; Depetris, I; Dhaliwal, M; Di Marino, P; Di Pietro, FR; Ding, X; Ding, Y; Djahel, S; Dong, Y; Du, H; Du, W; Du, XF; El-Fishawy, N; Fachler, T; Fan, H; Fan, X; Fang, L; Feng, N; Ferri, C; Ferry, R; Ficorella, C; Filippi, R; Fischbach, C; Flesch, H; Frasie, V; Fulgenzi, C; Gao, X; Garajova, I; Gardin, A; Gaudreau, PO; Gelsomino, F; Gershenwald, J; Ghidini, M; Ghiselli, S; Giampieri, R; Guan, W; Guihard, S; Guo, DW; Guo, H; Han, B; Han, JH; Harrison, MA; He, H; Hed, S; Heffernan, TP; Hermes, E; Hoang Vinh, L; Hofmann, A; Hong, C; Hou, H; Hou, X; Hu, B; Hu, J; Hu, Y; Huang, H; Huang, JJ; Huang, S; Hudgens, C; Huynh Thu, S; Hwu, P; Jha, V; Ji, J; Jiang, H; Jiang, Y; Jin, X; Johnson, S; Juengpanich, S; Jung, AC; Kalish, M; Kang, W; Kaur, H; Kim, HW; Knyazer, B; Lazar, AJ; Ledder, O; Lev Tzion, R; Li, B; Li, C; Li, H; Li, J; Li, S; Li, X; Li, Y; Li, YX; Lian, S; Liao, Y; Liu, C; Liu, M; Liu, XY; Liu, Y; Lombardi, P; Lu, L; Lu, Z; Malyugin, BE; Manzo, T; Mao, F; Marianeschi, SM; Marszalek, JR; Matlov Kormas, R; Morelli, C; Moursi, AS; Muellershausen, F; Nezi, L; Nguyen Quang, B; Nguyen Thi Hong, P; Nguyen Truong, G; Ni, B; Nigro, O; Niu, S; Orlanski Meyer, E; Overwijk, W; Pan, H; Pan, P; Pan, YH; Parisi, A; Park, H; Park, KB; Patruno, L; Petit, T; Petrillo, A; Porzio, G; Prieto, P; Pu, S; Purohit, H; Rachman, Y; Raghunathan, V; Rastogi, N; Reuben, A; Roberto, M; Roselló Keränen, S; Rudolph, B; Salvatore, L; Schubart, A; Schultz, P; Shah, M; Shashar, S; Shemasna, I; Shi, D; Shi, K; Shouman, MA; Shteyer, E; Singh, D; Song, X; Spinelli, GP; Sun, C; Sun, ZY; Szczepaniak Sloane, R; Tang, Z; Tawbi, H; Tetzlaff, MT; Thiéry, A; Topatana, W; Tortora, G; Turner, D; Uricchio, N; Venditti, O; Viola, N; Vitale, P; Wagner, P; Wang, D; Wang, H; Wang, J; Wang, JW; Wang, S; Wang, W; Wang, Y; Wani, K; Wargo, JA; Wen, F; White, MG; Witt, RG; Woodman, SE; Wren, BW; Wu, Z; Xie, Y; Xu, S; Xu, X; Xu, YC; Yadav, SP; Yan, X; Yang, C; Yang, S; Yang, WH; Yang, Y; Yao, Y; Yu, L; Yu, Y; Yue, M; Zanaletti, N; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, J; Zhang, L; Zhang, Q; Zhang, W; Zhang, Y; Zhao, Y; Zheng, P; Zhou, J; Zhou, Q; Zhu, Q; Zoratto, F; Zou, C; Zou, LG; Zurlo, IV	1
Habib, A; Nordmann, P; Poirel, L; Ruppé, E; Sadek, M; Zahra, R	1
Chen, Y; Ji, J; Liu, Z; Luo, Q; Xiao, Y; Xiong, L; Ying, C; Yu, W	1
McDermott, L; Snydman, DR	1
Cappellano, P; de Lima, AV; Lima, KO; Rocha, DADC; Sampaio, JLM; Sampaio, SCF	1
Boix-Palop, L; Bonnín-Pascual, J; Cano, A; Cisneros, JM; Gómez-Zorrilla, S; Jiménez-Jorge, S; Jimenez-Rodriguez, RM; López-Ruiz, J; Luckey, A; Martín-Gutiérrez, G; Montejo, JM; Padillo, J; Roca-Oporto, C; Rosso-Fernández, CM; Tallón-Aguilar, L; Torre-Cisneros, J	1
Bai, F; Chen, S; Cheng, Z; Jin, Y; Pan, X; Wei, X; Wu, W; Xu, C	1
Carbonnelle, E; Cohen, Y; Jaureguy, F; Jullien, V; Magréault, S; Méchaï, F; Toinon, D; Zahar, JR	1
Le Terrier, C; Nordmann, P; Poirel, L	1
Alonso-Garcia, I; Álvarez-Fraga, L; Arca-Suárez, J; Beceiro, A; Bou, G; Cendón-Esteve, A; Guijarro-Sánchez, P; Lasarte-Monterrubio, C; Maceiras, R; Martínez-Guitián, M; Outeda, M; Peña-Escolano, A; Vázquez-Ucha, JC	1
Livermore, DM; Mushtaq, S; Vickers, A; Woodford, N	1
Le Terrier, C; Nordmann, P; Poirel, L; Sadek, M	1
Gales, AC; Sahm, DF; Stone, G; Utt, E; Wise, MG	1
Chen, J; Jia, W; Jing, R; Li, J; Liu, Y; Sun, G; Sun, H; Wang, T; Xu, X; Xu, Y; Zhang, G	1
Feng, Y; Ma, K; Wu, S; Zong, Z	1
Bueno Lopes, LF; De Almeida Torres, N; Everson Uip, D; Morales Junior, R; Zeigler, R	1
Kamat, S; Karlowsky, JA; Mohamed, N; Sahm, DF; Wise, MG	1
Feng, Y; Ma, K; McNally, A; Zong, Z	1
Bouvier, M; Kerbol, A; Nordmann, P; Poirel, L; Sadek, M; Viguier, C	1
Bathoorn, E; Hughes, LA; Huis In 't Veld, RAG; Kampinga, GA; Vlaspolder, GL	1

Reviews

2 review(s) available for aztreonam and avibactam

Article	Year
New Delhi metallo-β-lactamase (NDM-1): an update. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Biotransformation; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Molecular Targeted Therapy; Sulbactam	2011
Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms. Journal of the Pediatric Infectious Diseases Society, 2019, Jul-01, Volume: 8, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Boronic Acids; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Meropenem; Tazobactam	2019

Article

Year

New Delhi metallo-β-lactamase (NDM-1): an update.

Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:5

Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Biotransformation; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Molecular Targeted Therapy; Sulbactam

2011

Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms.

Journal of the Pediatric Infectious Diseases Society, 2019, Jul-01, Volume: 8, Issue:3

Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Boronic Acids; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Meropenem; Tazobactam

2019

Trials

2 trial(s) available for aztreonam and avibactam

Article	Year
Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study. The Journal of antimicrobial chemotherapy, 2020, 03-01, Volume: 75, Issue:3 Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Ceftazidime; Drug Combinations; Humans; Intraabdominal Infections	2020
Factors associated with recruitment success in the phase 2a study of aztreonam-avibactam development programme: a descriptive qualitative analysis among sites in Spain. BMJ open, 2022, 02-03, Volume: 12, Issue:2 Topics: Azabicyclo Compounds; Aztreonam; Humans; Prospective Studies; Spain; Surveys and Questionnaires	2022

Other Studies

64 other study(ies) available for aztreonam and avibactam

Article	Year
A γ-Lactam Siderophore Antibiotic Effective against Multidrug-Resistant Gram-Negative Bacilli. Journal of medicinal chemistry, 2020, 06-11, Volume: 63, Issue:11 Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Catalytic Domain; Crystallography, X-Ray; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Half-Life; Lactams; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Penicillin-Binding Proteins; Pseudomonas aeruginosa; Siderophores	2020
Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases; Ceftazidime; Drug Combinations; Enterobacteriaceae; Microbial Sensitivity Tests	2011
Human simulated studies of aztreonam and aztreonam-avibactam to evaluate activity against challenging gram-negative organisms, including metallo-β-lactamase producers. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7 Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2013
In vitro activities of ceftazidime-avibactam and aztreonam-avibactam against 372 Gram-negative bacilli collected in 2011 and 2012 from 11 teaching hospitals in China. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3 Topics: Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftazidime; China; Drug Combinations; Drug Resistance, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; In Vitro Techniques; Microbial Sensitivity Tests	2014
Avibactam and class C β-lactamases: mechanism of inhibition, conservation of the binding pocket, and implications for resistance. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:10 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Drug Resistance, Multiple, Bacterial; Pseudomonas aeruginosa	2014
Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Computational Biology; Escherichia coli; Escherichia coli Infections; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Mutagenesis, Insertional; Penicillin-Binding Proteins; Sequence Analysis, DNA	2015
Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases. Diagnostic microbiology and infectious disease, 2015, Volume: 82, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Ceftaroline; Ceftazidime; Cephalosporins; Escherichia coli; Humans; Microbial Sensitivity Tests	2015
In vitro activity of aztreonam-avibactam against a global collection of Gram-negative pathogens from 2012 and 2013. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Drug Resistance, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2015
Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:9 Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactams; Disease Models, Animal; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Mice; Microbial Sensitivity Tests; Models, Biological; Treatment Outcome	2015
In Vitro Activities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases; Ceftazidime; Colistin; Drug Combinations; Enterobacteriaceae; Fosfomycin; Gene Expression; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline	2015
Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Ceftazidime; Dipeptides; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; France; Gene Expression; Humans; Microbial Sensitivity Tests; Plasmids; Prevalence; Prospective Studies	2016
In vitro pharmacokinetics/pharmacodynamics of the combination of avibactam and aztreonam against MDR organisms. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:7 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; Chromatography, Liquid; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Microbial Viability; Models, Theoretical; Tandem Mass Spectrometry	2016
Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:8 Topics: Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases; Ceftazidime; Drug Combinations; Enterobacteriaceae; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2016
Inhibitory activity of avibactam against selected β-lactamases expressed in an isogenic Escherichia coli strain. Diagnostic microbiology and infectious disease, 2016, Volume: 86, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Ceftaroline; Ceftazidime; Cephalosporins; Escherichia coli; Gene Expression; Humans; Microbial Sensitivity Tests	2016
Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission. International journal of antimicrobial agents, 2017, Volume: 49, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Germany; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Tazobactam; Young Adult	2017
Inhibition by Avibactam and Clavulanate of the β-Lactamases KPC-2 and CTX-M-15 Harboring the Substitution N Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:3 Topics: Amino Acid Motifs; Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftaroline; Ceftazidime; Cephalosporins; Clavulanic Acid; Cloning, Molecular; Drug Combinations; Escherichia coli; Gene Expression; Kinetics; Mutation; Recombinant Proteins; Reverse Genetics; Substrate Specificity	2017
Prediction of in vivo and in vitro infection model results using a semimechanistic model of avibactam and aztreonam combination against multidrug resistant organisms. CPT: pharmacometrics & systems pharmacology, 2017, Volume: 6, Issue:3 Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae Infections; Forecasting; Humans; Mice; Microbial Sensitivity Tests; Models, Biological; Pseudomonas Infections	2017
Structural/mechanistic insights into the efficacy of nonclassical β-lactamase inhibitors against extensively drug resistant Stenotrophomonas maltophilia clinical isolates. Molecular microbiology, 2017, Volume: 106, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Crystallography, X-Ray; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Stenotrophomonas maltophilia	2017
New Delhi Metallo-β-Lactamase 1 Catalyzes Avibactam and Aztreonam Hydrolysis. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Gram-Negative Bacteria; Humans; Hydrolysis; Microbial Sensitivity Tests	2017
Aztreonam-Avibactam Combination Restores Susceptibility of Aztreonam in Dual-Carbapenemase-Producing Enterobacteriaceae. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:8 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Citrobacter freundii; Drug Combinations; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Gene Expression; Humans; Isoenzymes; Klebsiella pneumoniae; Microbial Sensitivity Tests; Singapore	2018
TEM-184, a Novel TEM-Derived Extended-Spectrum β-Lactamase with Enhanced Activity against Aztreonam. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:9 Topics: Amino Acid Sequence; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Escherichia coli; Humans; Kinetics; Microbial Sensitivity Tests; Sequence Alignment; Tazobactam	2018
Microdialysis Study of Aztreonam-Avibactam Distribution in Peritoneal Fluid and Muscle of Rats with or without Experimental Peritonitis. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:10 Topics: Animals; Ascitic Fluid; Azabicyclo Compounds; Aztreonam; Male; Microdialysis; Muscle, Skeletal; Peritonitis; Rats; Rats, Sprague-Dawley	2018
Pharmacodynamic modelling of β-lactam/β-lactamase inhibitor checkerboard data: illustration with aztreonam-avibactam. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019, Volume: 25, Issue:4 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; Carbapenem-Resistant Enterobacteriaceae; Drug Interactions; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests	2019
Semimechanistic Pharmacodynamic Modeling of Aztreonam-Avibactam Combination to Understand Its Antimicrobial Activity Against Multidrug-Resistant Gram-Negative Bacteria. CPT: pharmacometrics & systems pharmacology, 2019, Volume: 8, Issue:11 Topics: Azabicyclo Compounds; Aztreonam; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Stability; Drug Synergism; Enterobacteriaceae; Microbial Sensitivity Tests; Models, Theoretical	2019
In vitro selection of aztreonam/avibactam resistance in dual-carbapenemase-producing Klebsiella pneumoniae. The Journal of antimicrobial chemotherapy, 2020, 03-01, Volume: 75, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases; Ceftazidime; Drug Combinations; Klebsiella pneumoniae; Microbial Sensitivity Tests	2020
Successful rescue treatment of sepsis due to a pandrug-resistant, NDM-producing Klebsiella pneumoniae using aztreonam powder for nebulizer solution as intravenous therapy in combination with ceftazidime/avibactam. The Journal of antimicrobial chemotherapy, 2020, 03-01, Volume: 75, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftazidime; Drug Combinations; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nebulizers and Vaporizers; Powders; Sepsis	2020
High prevalence of Escherichia coli clinical isolates in India harbouring four amino acid inserts in PBP3 adversely impacting activity of aztreonam/avibactam. The Journal of antimicrobial chemotherapy, 2020, 06-01, Volume: 75, Issue:6 Topics: Amino Acids; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftazidime; Drug Combinations; Escherichia coli; India; Microbial Sensitivity Tests; Prevalence	2020
Validation of Aztreonam-Avibactam Susceptibility Testing Using Digitally Dispensed Custom Panels. Journal of clinical microbiology, 2020, 03-25, Volume: 58, Issue:4 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftazidime; Drug Combinations; Enterobacteriaceae; Microbial Sensitivity Tests	2020
Genetic diversity and in vitro activity of ceftazidime/avibactam and aztreonam/avibactam against imipenem-resistant Enterobacteriaceae isolates in Southwest China: A single-centre study. Journal of global antimicrobial resistance, 2020, Volume: 22 Topics: Azabicyclo Compounds; Aztreonam; Ceftazidime; China; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Genetic Variation; Imipenem; Multilocus Sequence Typing	2020
Determining the optimal dosing of a novel combination regimen of ceftazidime/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection model. The Journal of antimicrobial chemotherapy, 2020, 09-01, Volume: 75, Issue:9 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftazidime; Drug Combinations; Enterobacteriaceae; Escherichia coli; Humans; Microbial Sensitivity Tests; Prospective Studies; Reproducibility of Results	2020
In vitro efficacy of ceftazidime-avibactam, aztreonam-avibactam and other rescue antibiotics against carbapenem-resistant Enterobacterales from the Arabian Peninsula. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 99 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Drug Combinations; Drug Resistance, Bacterial; Fosfomycin; Humans; Microbial Sensitivity Tests; Middle East; Tigecycline	2020
In vitro activity of aztreonam/avibactam against a global collection of Klebsiella pneumoniae collected from defined culture sources in 2016 and 2017. Journal of global antimicrobial resistance, 2021, Volume: 24 Topics: Africa; Anti-Bacterial Agents; Asia; Azabicyclo Compounds; Aztreonam; Europe; Klebsiella pneumoniae; Latin America; Middle East	2021
Treatment of invasive IMP-4 Enterobacter cloacae infection in transplant recipients using ceftazidime/avibactam with aztreonam: A case series and literature review. Transplant infectious disease : an official journal of the Transplantation Society, 2021, Volume: 23, Issue:2 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases; Ceftazidime; Drug Combinations; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Transplant Recipients	2021
Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019. The Journal of antimicrobial chemotherapy, 2021, 02-11, Volume: 76, Issue:3 Topics: Anti-Bacterial Agents; Asia; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftazidime; Enterobacteriaceae; Europe; Europe, Eastern; Latin America; Microbial Sensitivity Tests	2021
Optimization of Aztreonam in Combination With Ceftazidime/Avibactam in a Cystic Fibrosis Patient With Chronic Stenotrophomonas maltophilia Pneumonia Using Therapeutic Drug Monitoring: A Case Study. Therapeutic drug monitoring, 2021, 04-01, Volume: 43, Issue:2 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Ceftazidime; Child; Cystic Fibrosis; Drug Combinations; Drug Monitoring; Female; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Stenotrophomonas maltophilia	2021
Assessing the in vitro impact of ceftazidime on aztreonam/avibactam susceptibility testing for highly resistant MBL-producing Enterobacterales. The Journal of antimicrobial chemotherapy, 2021, 03-12, Volume: 76, Issue:4 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftazidime; Drug Combinations; Microbial Sensitivity Tests	2021
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients. The Journal of antimicrobial chemotherapy, 2021, 03-12, Volume: 76, Issue:4 Topics: Aged; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftazidime; Drug Combinations; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged	2021
Molecular characterization of clinical isolates of Enterobacterales with elevated MIC values for aztreonam-avibactam from the INFORM global surveillance study, 2012-2017. Journal of global antimicrobial resistance, 2021, Volume: 24 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Escherichia coli; Microbial Sensitivity Tests	2021
Successful use of avibactam and aztreonam combination for a multiresistant Stenotrophomonas maltophilia bloodstream infection in a patient with idiopathic medullary aplasia. Infectious diseases now, 2021, Volume: 51, Issue:7 Topics: Azabicyclo Compounds; Aztreonam; Bacteremia; Humans; Stenotrophomonas maltophilia	2021
Occurrence of Aztreonam-Avibactam-Resistant NDM-5-Producing Escherichia coli in the Food Chain. Antimicrobial agents and chemotherapy, 2021, 08-17, Volume: 65, Issue:9 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftazidime; Drug Combinations; Escherichia coli; Food Chain; Microbial Sensitivity Tests	2021
Aztreonam/avibactam effect on pharmacodynamic indices for mutant selection of Escherichia coli and Klebsiella pneumoniae harbouring serine- and New Delhi metallo-β-lactamases. The Journal of antimicrobial chemotherapy, 2021, 10-11, Volume: 76, Issue:11 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftazidime; Drug Combinations; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serine	2021
Recent Emergence of Aztreonam-Avibactam Resistance in NDM and OXA-48 Carbapenemase-Producing Escherichia coli in Germany. Antimicrobial agents and chemotherapy, 2021, 10-18, Volume: 65, Issue:11 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Germany; Microbial Sensitivity Tests	2021
Investigation of mechanisms responsible for decreased susceptibility of aztreonam/avibactam activity in clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019. The Journal of antimicrobial chemotherapy, 2021, 10-11, Volume: 76, Issue:11 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftazidime; Drug Combinations; Escherichia coli; Klebsiella pneumoniae; Latin America; Microbial Sensitivity Tests	2021
Selection and characterization of mutational resistance to aztreonam/avibactam in β-lactamase-producing Enterobacterales. The Journal of antimicrobial chemotherapy, 2021, 12-24, Volume: 77, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftazidime; Drug Combinations; Microbial Sensitivity Tests	2021
Successful treatment of Verona integron-encoded metallo-β-lactamase-producing European journal of hospital pharmacy : science and practice, 2022, Volume: 29, Issue:2 Topics: Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftazidime; Drug Combinations; Female; Humans; Integrons; Klebsiella pneumoniae; Microbial Sensitivity Tests	2022
SAGE open medicine, 2021, Volume: 9 Topics: Animals; Anti-Bacterial Agents; Antibodies, Protozoan; Antifungal Agents; Auranofin; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Canada; Candida; China; Clostridioides difficile; Cresols; Cross-Sectional Studies; Decarboxylation; Drug Resistance, Bacterial; Drug Resistance, Fungal; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Extraintestinal Pathogenic Escherichia coli; Female; Food Microbiology; Gastrointestinal Microbiome; Genomics; HIV Infections; Humans; Immunoglobulin G; Immunoglobulin M; Immunotherapy; Listeria monocytogenes; Listeriosis; Malaria; Male; Melanoma; Memory T Cells; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mink; Mitogen-Activated Protein Kinase Kinases; Molecular Epidemiology; Multilocus Sequence Typing; Pharmaceutical Preparations; Phenylacetates; Phylogeny; Plasmodium berghei; Pneumonia; Pregnancy; Proto-Oncogene Proteins B-raf; Risk Factors; RNA, Ribosomal, 16S; Saccharomycetales; Seroepidemiologic Studies; Toxoplasmosis; Virulence	2021
International circulation of aztreonam/avibactam-resistant NDM-5-producing Escherichia coli isolates: successful epidemic clones. Journal of global antimicrobial resistance, 2021, Volume: 27 Topics: Azabicyclo Compounds; Aztreonam; Clone Cells; Escherichia coli	2021
Frontiers in cellular and infection microbiology, 2021, Volume: 11 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Humans; Microbial Sensitivity Tests; Sepsis	2021
Microbiology spectrum, 2021, 12-22, Volume: 9, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacteria, Anaerobic; Bacterial Infections; Drug Evaluation, Preclinical; Humans; Microbial Sensitivity Tests	2021
A simple disk pre-diffusion test to predict in vitro aztreonam/avibactam activity against NDM-producing Klebsiella pneumoniae complex. Journal of global antimicrobial resistance, 2022, Volume: 28 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Ceftazidime; Cephalosporins; Klebsiella pneumoniae	2022
Development of Resistance to Eravacycline by Klebsiella pneumoniae and Collateral Sensitivity-Guided Design of Combination Therapies. Microbiology spectrum, 2022, 10-26, Volume: 10, Issue:5 Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Drug Collateral Sensitivity; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Porins; Protease La; Proteomics; Tetracyclines	2022
Automated HPLC-MS/MS assay for the simultaneous determination of ten plasma antibiotic concentrations. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2022, Nov-15, Volume: 1211 Topics: Anti-Bacterial Agents; Aztreonam; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drug Monitoring; Humans; Reproducibility of Results; Tandem Mass Spectrometry	2022
In vitro activity of aztreonam in combination with newly developed β-lactamase inhibitors against MDR Enterobacterales and Pseudomonas aeruginosa producing metallo-β-lactamases. The Journal of antimicrobial chemotherapy, 2022, 12-23, Volume: 78, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefiderocol; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas aeruginosa	2022
Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain. International journal of antimicrobial agents, 2023, Volume: 61, Issue:4 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Drug Combinations; Microbial Sensitivity Tests; Spain	2023
Activity of aztreonam/avibactam against metallo-β-lactamase-producing Enterobacterales from the UK: Impact of penicillin-binding protein-3 inserts and CMY-42 β-lactamase in Escherichia coli. International journal of antimicrobial agents, 2023, Volume: 61, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftazidime; Drug Combinations; Escherichia coli; Microbial Sensitivity Tests; Penicillin-Binding Proteins; United Kingdom	2023
In vitro activity of cefepime/zidebactam and cefepime/taniborbactam against aztreonam/avibactam-resistant NDM-like-producing Escherichia coli clinical isolates. The Journal of antimicrobial chemotherapy, 2023, 05-03, Volume: 78, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Escherichia coli; Microbial Sensitivity Tests	2023
Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017-2019. The Journal of antimicrobial chemotherapy, 2023, 07-05, Volume: 78, Issue:7 Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftazidime; Ciprofloxacin; Drug Combinations; Escherichia coli; Incidence; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa	2023
Microbiology spectrum, 2023, 06-15, Volume: 11, Issue:3 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Cefepime; Microbial Sensitivity Tests; Tigecycline	2023
Resistance to aztreonam-avibactam due to a mutation of SHV-12 in Enterobacter. Annals of clinical microbiology and antimicrobials, 2023, Jun-26, Volume: 22, Issue:1 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Combinations; Enterobacter; Humans; Microbial Sensitivity Tests; Mutation	2023
Synergistic combination of aztreonam and ceftazidime/avibactam against resistant Stenotrophomonas maltophilia on pancreatitis. Journal of infection in developing countries, 2023, 06-30, Volume: 17, Issue:6 Topics: Acute Disease; Aged; Anti-Bacterial Agents; Aztreonam; Ceftazidime; Diabetes Mellitus, Type 2; Drug Combinations; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Pancreatitis; Stenotrophomonas maltophilia	2023
In vitro activity of aztreonam-avibactam against Enterobacterales isolates collected in Latin America, Africa/Middle East, Asia, and Eurasia for the ATLAS Global Surveillance Program in 2019-2021. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2023, Volume: 42, Issue:9 Topics: Anti-Bacterial Agents; Asia; Aztreonam; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Enterobacteriaceae; Humans; Latin America; Microbial Sensitivity Tests; Middle East	2023
Hijacking a small plasmid to confer high-level resistance to aztreonam-avibactam and ceftazidime-avibactam. International journal of antimicrobial agents, 2023, Volume: 62, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Escherichia coli; Microbial Sensitivity Tests; Plasmids	2023
Rapid Aztreonam/Avibactam NP test for detection of aztreonam/avibactam susceptibility/resistance in Enterobacterales. Journal of clinical microbiology, 2023, 10-24, Volume: 61, Issue:10 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Drug Combinations; Humans; Microbial Sensitivity Tests	2023
Enhancement and Comparison of (Ceftazidime-)Avibactam Plus Aztreonam Susceptibility Tests for Stenotrophomonas maltophilia in Clinical Diagnostics. Current microbiology, 2023, Dec-05, Volume: 81, Issue:1 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Ceftazidime; Microbial Sensitivity Tests; Reproducibility of Results; Stenotrophomonas maltophilia	2023